ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,rank,leading_edge,core_enrichment,gs_description,results_path
FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,69,-0.802453609616943,-2.51867297174249,1e-10,6e-10,2.67942583732057e-10,247,tags=75%, list=11%, signal=69%,GLUL/SDCBP/TPM4/ZYX/CTSD/THEMIS2/ANXA1/FKBP1A/CTSB/CLEC12A/TGFBI/CD63/TIMP2/VIM/PTPRE/CEBPB/GLIPR1/PLBD1/RHOC/CD36/TBXAS1/LRP1/PTPN6/CAPG/FCGRT/ANXA5/IGSF6/NPC2/ANXA2/RNF130/FOS/SH3BGRL3/LGALS3/TSPO/S100A10/ZEB2/FGL2/FGR/CYBB/S100A11/IFI30/S100A4/MNDA/SPI1/LGALS1/S100A6/AIF1/CTSS/FTL/TYROBP/LYZ/CST3,Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth,C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,50,0.739320408906161,2.67404220769209,1e-10,6e-10,2.67942583732057e-10,491,tags=80%, list=21%, signal=64%,C12orf57/RPL3/RPS25/RPS4X/EEF1A1/RPS3/RPS27A/RPL30/RPS18/EEF1B2/RPL5/RPS6/TPT1/RPS5/RPS14/RPS29/RPL35A/RPL4/RPS8/RPL18/RPL22/TOMM7/RPLP0/EIF4B/GPR183/RPS13/EEF2/STMN3/RPL13A/FOXO1/RPL37A/STAT5B/RPS20/EIF3L/FAU/EIF3F/RPL27/GLS/SORL1/FBL,Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 3D,C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,95,0.68601148276363,2.79087852333625,1e-10,6e-10,2.67942583732057e-10,271,tags=55%, list=12%, signal=50%,IL7R/LDHB/C12orf57/RPL3/RPS25/RPS4X/EEF1A1/RPS3/RGCC/RPS27A/RPS15A/RPL30/RPS18/EEF1B2/RPL5/RPS6/RPL14/TPT1/RPL13/RPS5/RPS14/RPS29/RPL9/RPL35A/RPS3A/RPL10A/RPL11/ITM2A/RPL4/RPS23/RPL39/RPS8/RPL18/RPL22/HINT1/TOMM7/RPLP0/PRDX2/EIF4B/GPR183/RPS10/RPS13/EEF2/SNRPN/RPL7A/PABPC1/STMN3/ATM/RPL31/RPL13A/RPLP1/EIF2S3,Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 7D,C7/VAX
HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,213,-0.725741818174163,-2.55134979042174,1e-10,6e-10,2.67942583732057e-10,509,tags=64%, list=22%, signal=55%,BNIP3L/MYO9B/EIF4A1/NFKBIA/PICALM/SHKBP1/UBC/TMEM167A/TM9SF2/PTTG1IP/ZBTB7A/SOD2/CYC1/TMEM154/UBE2D1/STX10/NRROS/VMP1/ZFAND5/ATP5F1B/SRSF9/CAT/RNASET2/ATOX1/NADK/RHBDF2/CMTM6/RAB5C/GLUL/SDCBP/IFNGR1/MAN2B1/BACH1/SCPEP1/COX5B/NCOA4/ATP6V1F/MOB1A/MYD88/NCF4/THEMIS2/SKAP2/ANXA1/EIF4EBP1/UBE2J1/REL/MIS18BP1/EVI2B/UNC93B1/PLCG2/HERPUD1/RAB11FIP1/IER2/CIITA/GRINA/BTK/RNASE6/RNASEK/CDA/SWAP70/SNX2/OGFRL1/CLEC12A/FGD2/CXXC5/TGFBI/ZNF385A/C19orf38/ODF3B/SCIMP/NCF1C/LYST/SNX10/LILRB1/YBX3/ALDH2/SERPINB1/TIMP2/VIM/TNFRSF1B/GNG5/PTPRE/CEBPB/DUSP6/IFNGR2/ASAH1/PLBD1/ATP6V0C/ALOX5/HLA-DMB/PGD/TBXAS1/LY86/MYO1F/GNAI2/ATP6V0B/POU2F2/CD302/PILRA/BLVRB/MPEG1/NCF1/SYK/MEF2C/CSF3R/APLP2/NCF2/IGSF6/GAPDH/RNF130/SRGN/PLEK/CD68/HLA-DMA/PYCARD/LYN/TNFAIP2/TKT/CTSZ/CYBB/GRN/COTL1/IFI30/SAT1/GSTP1/CEBPD/SPI1/FTH1/HLA-DRB5/FTL/FCN1/HLA-DRB1/TYROBP/HLA-DRA/LYZ/CST3,Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 28D,C7/VAX
HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,76,-0.885505396408775,-2.82897559022959,1e-10,6e-10,2.67942583732057e-10,227,tags=87%, list=10%, signal=81%,LILRB3/FGD2/TGFBI/GCA/DUSP1/ZNF385A/C19orf38/ODF3B/LMO2/PRAM1/JUNB/SLC11A1/LILRA5/JAML/YBX3/ALDH2/SLC7A7/CLEC7A/TIMP2/CEBPB/IFNGR2/MARCKS/PLBD1/LRRC25/ALOX5/RAB32/TNFSF13B/CD36/LY86/LRP1/FPR1/CTSH/MPEG1/NCF1/CSF3R/NCF2/CFP/LILRB2/IGSF6/MS4A7/HCK/CPVL/CSTA/TNFAIP2/CD14/MS4A6A/CYBB/CFD/TYMP/IFI30/S100A12/HLA-DQB1/MNDA/VCAN/SPI1/HLA-DQA1/AIF1/SERPINA1/HLA-DRB5/FCN1/HLA-DRB1/HLA-DRA/S100A9/LYZ/CST3/S100A8,Genes down-regulated in natural killer cell 3d vs 0d in adults after exposure to 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), B/Brisbane/60/2008) , time point 3D. Comment: Down-regulated DE RNA transcripts (down >= 1.5x) shared between both TIV-vaccinated donors,C7/VAX
HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,83,-0.802394409496751,-2.58918588374279,1e-10,6e-10,2.67942583732057e-10,259,tags=77%, list=11%, signal=71%,PARP14/PSMB9/LAP3/GLUL/IRF1/BACH1/MT2A/IRF7/TNFSF10/PSME2/GRINA/ATP6V1B2/NCF1B/CTSB/LILRB3/OAS1/GCA/DUSP1/ODF3B/SCIMP/LMO2/NCF1C/CASP1/LILRA5/SNX10/LILRB1/DUSP6/IFNGR2/MARCKS/PLBD1/TNFSF13B/CD36/FPR1/PLEKHO1/CALHM6/RAB31/CARD16/MPEG1/TMEM176B/NCF1/LILRB2/IGSF6/NPC2/HCK/FOS/SRGN/LYN/FGL2/TNFAIP2/CD14/TYMP/IFI30/S100A12/MNDA/VCAN/IFITM3/AIF1/SERPINA1/CTSS/FCER1G/FCN1/S100A9/LYZ/S100A8,Genes up-regulated in peripheral blood mononuclear cell vaccinated with AS03 adjuvant vs phosphate-bufferred saline in adults (19-39) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 1D , administered i.m.,C7/VAX
KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,55,0.722944642024937,2.63166761473835,1e-10,6e-10,2.67942583732057e-10,376,tags=56%, list=16%, signal=48%,NOSIP/C12orf57/TRAT1/RPL3/RPS3/LEPROTL1/EEF1B2/RPS6/ITK/RPL35A/RPS3A/RPL10A/ITM2A/CD28/RPL24/RPL17/RPL18A/RPLP0/RPL6/BCL11B/GPR183/RASGRP1/EIF3E/SNHG6/RPL38/STMN3/CLDND1/DOCK10/SLC7A6/EIF3H/UXT,Genes up-regulated in blood cohort 1 (re-vaccinated in 6-9 months) vs cohort 2 (re-vaccinated in 12-13 months) in adults (65+) after exposure to 2012-2013 seasonal trivalent inactivated influenza vaccine (TIV) , time point N/A. Comment: Cohort 1 (re-vaccinated in 6-9 months) vs Cohort 2 (re-vaccinated in 12-13 months),C7/VAX
NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,146,0.526291099123713,2.3045713606369,1e-10,6e-10,2.67942583732057e-10,617,tags=45%, list=27%, signal=35%,CD6/SPOCK2/PIK3IP1/RGCC/RCAN3/DGKA/RPL10/BTG1/GAS5/IL6ST/ACAP1/RHOH/CYLD/HINT1/PDE7A/AAK1/SEMA4D/GPR183/NAP1L4/CYTIP/FAM102A/RORA/TNFRSF25/UBALD2/PABPC1/GATA3/STMN3/SPTAN1/HNRNPA1/DNAJB1/ARMH1/RACK1/PHF1/DDX24/CDKN1B/CLDND1/ITPKB/FUS/ZBTB25/SFI1/PPP2R5C/PDCD4/GOLGA8B/SERINC1/CIRBP/OGT/SORL1/RRP1B/TUT4/PARP8/MPHOSPH8/CHD2/PCBP2/PNISR/SNRK/SBDS/MED10/PHF3/PCNX1/ASXL1/NOP58/KLHDC2/SF3A1/NKTR/SLC2A3,Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.,C7/VAX
NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,134,0.66836336196699,2.85804115752755,1e-10,6e-10,2.67942583732057e-10,539,tags=59%, list=24%, signal=48%,LEF1/NOSIP/CD3D/CAMK4/CD3G/C12orf57/TRAT1/AQP3/PIK3IP1/RGCC/RCAN3/ITK/TC2N/OXNAD1/MALAT1/GAS5/IL6ST/ITM2A/CD28/RPL37/MGAT4A/RHOH/PPP1R2/TRAC/OCIAD2/ITGA6/ARL4C/BCL11B/GPR183/MAML2/LY9/SNRPN/RORA/STK4/THEMIS/STMN3/KCNA3/DNAJB1/ARMH1/SF1/FOXP1/SNHG8/NUCB2/CLDND1/TNIK/ITPKB/FOXO1/STK17A/SFXN1/CDC42SE2/FUS/PIK3R1/SH3YL1/SYNE2/ANKRD12/SLC38A1/ZBTB25/TMEM106B/CNST/URI1/PRKACB/TGFBR2/GOLGA8B/STAT4/TMEM243/EML4/TOMM20/STT3B/TTC3/MPHOSPH8/CHD2/PCBP2/PNISR/RBM38/SNRK/SBDS/DANCR/PTPN4/TPP2,Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).,C7/VAX
NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,147,-0.709558542436731,-2.42241004134474,1e-10,6e-10,2.67942583732057e-10,377,tags=56%, list=16%, signal=50%,NADK/CKLF/CLTA/ARAP1/CAP1/SULT1A1/SH3BP2/ZYX/CSTB/CTSD/NCF4/SKAP2/LYL1/PIK3AP1/CD300A/ADA2/TCIRG1/GLRX/BTK/PRKCD/C1orf162/ATP6V1B2/NCF1B/C4orf48/LILRB3/CPPED1/FGD2/IQGAP1/GCA/PAK1/NAGK/CAPNS1/PRAM1/ATP6V0D1/NCF1C/LYST/LAT2/CASP1/SLC11A1/JAML/LILRB1/AGTRAP/TPI1/SERPINB1/TIMP2/IFITM2/IFNGR2/PECAM1/CD36/TBXAS1/SERF2/LRP1/PTPN6/POU2F2/PILRA/MPEG1/CX3CR1/ARPC1B/NCF1/SYK/CAPG/CSF3R/PRELID1/APLP2/NCF2/LILRB2/MS4A7/HCK/BRI3/PYCARD/FGL2/TNFAIP2/EFHD2/CFD/TYMP/GRN/S100A11/IFI30/MNDA/IFITM3/LST1/SERPINA1,Genes positively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).,C7/VAX
NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,155,0.527726427684749,2.31951752865425,1e-10,6e-10,2.67942583732057e-10,459,tags=43%, list=20%, signal=37%,LEF1/CAMK4/TRAT1/CD6/SPOCK2/RPS27/RGCC/DGKA/FLT3LG/TRAF3IP3/TESPA1/MALAT1/GAS5/IL6ST/TAGAP/RPL37/CYLD/PPP1R2/HINT1/PDE7A/CD96/PSIP1/ARL4C/BCL11B/LY9/CLEC2D/RORA/TNFRSF25/STK4/PABPC1/THEMIS/GATA3/HNRNPA1/MBNL1/DNAJB1/ARMH1/SF1/FOXP1/DDX24/TMEM63A/EIF4A2/ITPKB/STK17A/FUS/PIK3R1/SRSF5/HELB/URI1/EPC1/LINS1/DYRK2/SLC7A6/CCDC66/STAT5B/CD69/SFI1/PPP2R5C/TGFBR2/GOLGA8B/STAT4/CALM1/UXS1/EML4/SPTBN1/OGT/FGD3,Genes negatively correlated with HAI response at 28d in peripheral blood mononuclear cell in adults (18-50) after exposure to Fluarix/Fluvirin , time point 7D. Comment: Supplementary Table 5: All genes whose expression (d3/d0 or d7/d0) correlates to the fold increase in HAI titers (d28/d0).,C7/VAX
NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,210,-0.682916217681131,-2.40254521200354,1e-10,6e-10,2.67942583732057e-10,462,tags=54%, list=20%, signal=47%,ILK/CSK/TMBIM4/RAB10/CYC1/LSM10/PDIA6/MX1/ZFAND5/TPST2/IFI16/MFSD1/MEGF9/ENY2/WSB1/ENO1/PSMB10/PARP14/NADK/CIAO2A/PSMB9/CLTA/ARPC5/PLAC8/SULT1A1/ATP5MF/SCPEP1/NOTCH2/ZNF106/CSTB/MYD88/IRF7/EHBP1L1/COX5A/REEP5/RGS19/QKI/TNFSF10/PPT1/COMT/GSTO1/UNC93B1/PIK3AP1/ADA2/GDI2/CIITA/GLRX/BTK/CTSC/DYNLL1/BST2/ATP6V1B2/NUP214/CTSB/STX7/OAS1/SNX2/RNH1/FGD2/AOAH/NAGK/CAST/LMO2/PRAM1/ATP6V0D1/CRTAP/CASP1/PGLS/LILRB1/AGTRAP/TPI1/ALDH2/SLC7A7/SERPINB1/HVCN1/PECAM1/PLBD1/LTA4H/AP2S1/HLA-DMB/TNFSF13B/CD36/PGD/TBXAS1/SERF2/CARD16/CD302/MPEG1/ARPC1B/SYK/MEF2C/PRELID1/APLP2/AP1S2/CFP/HCK/CPVL/PYCARD/FGL2/TKT/CD14/MS4A6A/FGR/CYBB/GRN/IFI30/GSTP1/AIF1/CTSS/FCER1G/FCN1/HLA-DRB1/CST3,Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.,C7/VAX
OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,240,0.741780901907147,3.33798790868491,1e-10,6e-10,2.67942583732057e-10,445,tags=64%, list=19%, signal=57%,IL7R/TCF7/CD3E/LDHB/LEF1/LINC00861/IL32/ETS1/CAMK4/CD3G/C12orf57/LCK/PRKCQ-AS1/TRAT1/INPP4B/RPL3/CD27/CD6/SPOCK2/PIK3IP1/MAL/RPS3/LDLRAP1/RCAN3/RPL5/DGKA/RPS6/RPL14/RPL13/ITK/TC2N/TRAF3IP3/TRABD2A/OXNAD1/ABLIM1/TESPA1/CD2/DENND2D/BTG1/NOP53/GAS5/SKAP1/PCED1B/ITM2A/CD40LG/CD28/RPL4/RBL2/RPL37/THEM4/MGAT4A/SATB1/TMC8/S1PR1/ZAP70/MYC/TMEM204/SUN2/OCIAD2/ARHGAP15/PDE7A/AAK1/CD96/RPL23A/ADD3/SIRPG/ITGA6/PSIP1/ARL4C/RASA3/PRKCH/BCL11B/EIF4B/GPR183/TBC1D10C/LY9/CLEC2D/EPHX2/CD247/PDE3B/FCMR/FYN/RASGRP1/SNRPN/SERINC5/APBB1/FAM102A/RORA/BIN1/SNHG6/CHMP7/MZT2A/PABPC1/THEMIS/GATA3/STMN3/LINC01550/SPTAN1/IL16/ATM/BCL2/RPL13A/KIF2A/CHD3/RETREG1/ATP8B2/MLLT3/FOXP1/PEBP1/NBPF15/NUCB2/FAM107B/CYFIP2/PRKCA/ITPKB/FOXO1/SFXN1/PIK3R1/PITPNC1/SH3YL1/TSTD1/TXK/SLC38A1/ZBTB25/TOB1/URI1/THOC3/RASA2/DYRK2/ASF1A/SLC7A6/HMOX2/GPRIN3/PRKACB/NPAT/RPS20/DEF6/LIX1L/SFI1/PACS1/ZNF862/EIF3L/GOLGA8B/EIF3F/STAT4/TMC6/CALM1/UXS1/ESYT2/REST/ODF2L/HNRNPDL/SPTBN1,Genes down-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.,C7/VAX
OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,457,-0.670810467492185,-2.45245250785967,1e-10,6e-10,2.67942583732057e-10,554,tags=54%, list=24%, signal=51%,PPP4C/XAF1/TMEM179B/HIGD2A/ATP6V0E1/PSMA4/NINJ1/CD53/RILPL2/IFI6/OGFR/TRIM38/CTSA/SP110/SQSTM1/GNB1/MGAT1/RCSD1/STAT2/NFKBIA/APOBEC3G/OS9/PSMB8/TAF10/PRKAR1A/FBXL5/SPG21/VAMP5/DRAP1/AKR1A1/TM9SF2/RNF213/PTTG1IP/ILK/DOCK8/NOP10/SOD2/RAB10/CYC1/LSM10/DYNLT1/PDIA6/TMEM154/MX1/UBE2D1/STX10/ETV6/SUPT4H1/VMP1/TMEM219/ATP5F1B/ATG16L2/CHMP4B/ADGRE5/IFI16/TPP1/TMSB10/LMO4/UQCRC1/CAPZA2/WSB1/CALR/PSMB10/PARP14/NADK/GLIPR2/COPE/RHBDF2/CMTM6/PSMB9/LY6E/RAB5C/LAP3/COX6B1/GLUL/ARPC5/POMP/DAPP1/SH3BGRL/TUBA1A/IRF1/BACH1/PLAC8/HSH2D/SCPEP1/MBD2/COX5B/SH3BP2/MOB1A/PSMB3/MYD88/MT2A/IRF7/ARRB2/EHBP1L1/THEMIS2/RGS19/TPM3/UBE2J1/REL/QKI/TNFSF10/ATG3/BID/EVI2B/GSTO1/UNC93B1/PIK3AP1/LCP1/CD300A/GRB2/ADA2/GDI2/EMP3/IER2/CIITA/PSME2/TCIRG1/VASP/GLRX/BTK/BST2/PRKCD/TUBA1B/C1orf162/ATP6V1B2/VSIR/RAB24/RHOG/NCF1B/CTSB/LILRB3/OAS1/SNX2/RNH1/CPPED1/FGD2/GNB2/GCA/DUSP1/PAK1/MTPN/C19orf38/AOAH/ODF3B/LGALS9/NAGK/SCIMP/CAST/LMO2/ATP6V0D1/NCF1C/JUNB/LAT2/CASP1/LILRA5/SNX10/LILRB1/ALDH2/SLC7A7/SYNGR2/CLEC7A/SERPINB1/IFITM2/TNFRSF1B/GNG5/PTPRE/CEBPB/DUSP6/IFNGR2/MARCKS/AP2S1/HLA-DMB/TNFSF13B/CD36/PLEKHO1/CALHM6/PTPN6/RAB31/CARD16/LSP1/CTSH/RAC1/MPEG1/ARPC1B/NCF1/CAPG/GPX1/CSF3R/PRELID1/AP1S2/ANXA5/NCF2/CFP/LILRB2/IGSF6/MS4A7/NPC2/ARPC3/HCK/ANXA2/SRGN/PLEK/CD68/CPVL/HLA-DMA/CLIC1/ZEB2/BRI3/PYCARD/LYN/FGL2/TNFAIP2/CD14/GABARAP/MS4A6A/FGR/NAPSB/EFHD2/CTSZ/CYBB/TYMP/GRN/CYBA/COTL1/IFI30/SAT1/MNDA/IFITM3/LGALS1/AIF1/SERPINA1/CTSS/FTL/HLA-DPB1/PSAP/FCER1G/HLA-DPA1/FCN1/HLA-DRB1/TYROBP/HLA-DRA/CD74/LYZ/CST3,Genes up-regulated in blood 24hr vs 0hr in adults (18-50) (high dose subjects) after exposure to ChAd63-KH , time point 24H , administered Intramuscular injection. Comment: DE gene list for high dose subjects.,C7/VAX
PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,42,-0.834038380578754,-2.40660279485695,1e-10,6e-10,2.67942583732057e-10,283,tags=74%, list=12%, signal=66%,EVI2B/PIK3AP1/LCP1/FKBP1A/CTSB/CLEC12A/SLC7A7/CLEC7A/MARCKS/GLIPR1/RAB32/LY86/CALHM6/TIMP1/MPEG1/CX3CR1/ARPC1B/AP1S2/LILRB2/IGSF6/SRGN/CPVL/MS4A6A/CTSZ/CYBB/AIF1/SERPINA1/CTSS/FCER1G/TYROBP/LYZ,Genes up-regulated in skin of body 3d vs 0hr in adults (70-93) (VZV challenge) after exposure to Zostavax , time point 3D,C7/VAX
SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,86,0.707304320640765,2.82895876994052,1e-10,6e-10,2.67942583732057e-10,329,tags=63%, list=14%, signal=56%,IL7R/TCF7/LDHB/CCR7/CD3D/LTB/CD3G/C12orf57/LCK/INPP4B/SPOCK2/RPS27/RPS15A/RPS18/EEF1B2/RPL14/RPL13/TRAF3IP3/ABLIM1/CD2/RPS29/RPS21/RPL9/RPS3A/RPL10A/SKAP1/PCED1B/ITM2A/RPS28/RPL37/CDC25B/LAT/RHOH/ZAP70/HINT1/RPS16/RPL23A/ARL4C/PRKCH/RPS10/NAP1L4/PDE3B/SNRPN/BIN1/GATA3/IL16/RPL13A/RPL12/PEBP1/CYFIP2/ITPKB/FOXO1/TXK/SLC38A1,Genes down-regulated in peripheral blood mononuclear cell (5 to 7)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 5 to 7D,C7/VAX
SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,114,-0.763955198938957,-2.55054104137172,1e-10,6e-10,2.67942583732057e-10,366,tags=65%, list=16%, signal=57%,ATOX1/PSMB10/PSMB9/LY6E/LAP3/RNPEP/TPM4/IRF1/BACH1/PSMB3/MYD88/IRF7/THEMIS2/TNFSF10/GSTO1/GRB2/PSME2/GLRX/ATP6V1B2/RAB24/RHOG/CTSB/LILRB3/OAS1/GCA/LGALS9/CAST/LMO2/CASP1/CD63/SNX10/LILRB1/IFITM2/TNFRSF1B/CEBPB/IFNGR2/MARCKS/CD36/FPR1/NCF1/CAPG/AP1S2/ANXA5/NCF2/IGSF6/NPC2/ARPC3/HCK/ANXA2/CPVL/TSPO/LYN/FGL2/MS4A6A/EFHD2/CYBB/GRN/IFI30/HLA-DQB1/MNDA/NKG7/IFITM3/LST1/AIF1/SERPINA1/CTSS/HLA-DPB1/PSAP/HLA-DPA1/FCN1/HLA-DRB1/HLA-DRA/S100A9/CD74,Genes up-regulated in peripheral blood mononuclear cell (5 to 7)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 5 to 7D,C7/VAX
SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,121,0.577170541207374,2.44031468502718,1e-10,6e-10,2.67942583732057e-10,253,tags=40%, list=11%, signal=37%,LDHB/CD3D/LTB/C12orf57/RPL3/RPS4X/RPS3/RPS27A/RPS15A/EEF1B2/RPL5/RPSA/RPS6/RPL13/RPS5/RPS14/EEF1G/RPL10/RPL36/RPS21/RPL9/RPL35A/RPS3A/RPL10A/RPL11/RPL39/RPL18/RPL22/ZAP70/TOMM7/RPL18A/EEF1D/RPL23A/ITGA6/ARL4C/RPL6/EIF4B/RPS2/RPS10/RPS15/RPS13/RPS7/EEF2/EIF3E/RPL7A/SLC2A4RG/RACK1/TNFAIP8,Genes down-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D,C7/VAX
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,237,-0.599129427147263,-2.1218774673233,1e-10,6e-10,2.67942583732057e-10,347,tags=32%, list=15%, signal=31%,DAPP1/MAN2B1/IRF1/SULT1A1/HSH2D/SCPEP1/MBD2/PARVG/ZYX/NCF4/IRF7/EHBP1L1/CUX1/COMT/NBPF14/HERPUD1/ADA2/RAB11FIP1/CFL1/TCIRG1/COX8A/PRKCD/C1orf162/VSIR/RAB24/RHOG/CTSB/LILRB3/ODF3B/NAGK/PRAM1/CRTAP/SLC11A1/LILRB1/ALDH2/CLEC7A/IFITM2/TNFRSF1B/PTPRE/CEBPB/ASAH1/ALOX5/ALDOA/CD302/PILRA/MPEG1/NCF1/FCGRT/CSF3R/ITGB2/HLA-DMA/S100A10/BRI3/LYN/FGR/EFHD2/CFD/GRN/CYBA/COTL1/S100A11/S100A4/MNDA/SPI1/IFITM3/HLA-DQA1/LST1/SERPINA1/FTL/PSAP/FCER1G/FCN1/HLA-DRB1/TYROBP/CD74/LYZ/CST3,Genes down-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D,C7/VAX
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,303,0.743264687056692,3.48750758591227,1e-10,6e-10,2.67942583732057e-10,400,tags=68%, list=17%, signal=64%,IL7R/TCF7/CD3E/LDHB/LEF1/LINC00861/CCR7/CD3D/IL32/ETS1/CAMK4/LTB/CD3G/PCED1B-AS1/C12orf57/LCK/PRKCQ-AS1/TRAT1/AQP3/INPP4B/RPL3/CD27/CD6/SPOCK2/PIK3IP1/RPS4X/MAL/EEF1A1/EVL/RPS3/RGCC/CD5/LDLRAP1/RCAN3/RPL32/RPS15A/RPL30/RPS18/RPL5/DGKA/RPS6/NPM1/CD7/RPL13/RPS5/ITK/TC2N/RPS14/TRABD2A/EEF1G/OXNAD1/ABLIM1/TESPA1/CD2/DENND2D/RPS29/MALAT1/BTG1/NOP53/RPS21/GAS5/RPL35A/PBXIP1/SKAP1/PCED1B/RPL11/ITM2A/CD40LG/CD28/RPL4/GYPC/RBL2/RPS23/RPL37/CDC25B/RPL24/THEM4/MGAT4A/LAT/SATB1/LBH/RHOH/RPL18/RPL22/S1PR1/ZAP70/RPL17/TMEM204/TRAC/HINT1/SUN2/OCIAD2/RPS16/RPLP0/RPL29/ARHGAP15/PDE7A/AAK1/CD96/TRBC2/SIRPG/NCK2/ITGA6/PSIP1/ARL4C/RASA3/PRKCH/RPL6/PRDX2/BCL11B/EIF4B/RPS15/RPS13/MAML2/LY9/SOD1/SCML4/CLEC2D/EPHX2/PLCG1/CD247/EEF2/PDE3B/FCMR/RPLP2/FYN/RASGRP1/SERINC5/APBB1/FAM102A/RORA/BIN1/EIF3E/SIT1/CHMP7/MZT2A/PABPC1/THEMIS/RPS19/LINC01550/CHRM3-AS2/KCNA3/SPTAN1/IL16/ATM/BCL2/DNAJB1/RACK1/RPL26/ST13/RPL12/CHD3/RPLP1/EIF2S3/RETREG1/ATP8B2/FOXP1/PEBP1/SNHG8/NUCB2/FAM107B/CYFIP2/TNIK/PRKCA/EIF4A2/ITPKB/FOXO1/STK17A/TTC39C/SFXN1/CDC42SE2/PITPNC1/SH3YL1/TSTD1/SESN3/RPL37A/TXK/SLC38A1/ZBTB25/TOB1/NSA2/SRSF5/URI1/CMPK1/RPL8/ABHD14B/RASA2/HIVEP2/ST3GAL1/DYRK2/SLC7A6/ANP32B/ESYT1/EIF3H/RSL1D1/UXT/PRKACB/NPAT/RPS20/SRSF8/KMT2A/CCNG1/PACS1/RPL35/DDX6,Genes down-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types,C7/VAX
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,254,-0.752736154265177,-2.68115423002467,1e-10,6e-10,2.67942583732057e-10,394,tags=60%, list=17%, signal=56%,CAPZA2/WSB1/RNASET2/ATOX1/PSMB10/PARP14/NADK/GLIPR2/RHBDF2/PSMB9/LY6E/LAP3/RNPEP/GLUL/POMP/DAPP1/TUBA1A/IRF1/BACH1/PLAC8/HSH2D/SCPEP1/NOTCH2/SH3BP2/MYD88/CTSD/NCF4/MT2A/IRF7/EHBP1L1/THEMIS2/SKAP2/TNFSF10/ATG3/BID/BLOC1S1/GSTO1/UNC93B1/PIK3AP1/CD300A/ADA2/EMP3/PSME2/GRINA/TCIRG1/GLRX/BTK/BST2/PRKCD/C1orf162/ATP6V1B2/RAB24/CTSB/LILRB3/OAS1/ABI3/SNX2/RNH1/CLEC12A/CPPED1/FGD2/GNB2/GCA/PAK1/AOAH/ODF3B/LGALS9/NAGK/SCIMP/LMO2/ATP6V0D1/LYST/LAT2/CASP1/SLC11A1/CD63/LILRA5/SNX10/LILRB1/AGTRAP/SLC7A7/CLEC7A/TIMP2/IFITM2/TNFRSF1B/GNG5/PTPRE/CEBPB/DUSP6/IFNGR2/MARCKS/LRRC25/ALOX5/HLA-DMB/TNFSF13B/CD36/FPR1/PLEKHO1/CALHM6/TIMP1/RAB31/CARD16/PILRA/TMEM176B/CAPG/CSF3R/PRELID1/ANXA5/NCF2/CFP/LILRB2/IGSF6/MS4A7/NPC2/HCK/ANXA2/STXBP2/PLEK/CD68/HLA-DMA/CLIC1/ZEB2/PYCARD/LYN/FGL2/TNFAIP2/CD14/MS4A6A/FGR/EFHD2/CTSZ/CYBB/CFD/TYMP/GRN/CYBA/S100A11/IFI30/SAT1/MNDA/SPI1/IFITM3/LST1/SERPINA1/HLA-DRB5/FCER1G/HLA-DPA1/FCN1/HLA-DRB1/TYROBP/HLA-DRA/S100A9/CST3,Genes up-regulated in peripheral blood mononuclear cell 1d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Table includes specific cell types,C7/VAX
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,55,0.70780392745853,2.5765522907257,1e-10,6e-10,2.67942583732057e-10,334,tags=69%, list=15%, signal=60%,LDHB/CCR7/CD3D/ETS1/CAMK4/C12orf57/INPP4B/CD27/RCAN3/ITK/TC2N/TRABD2A/ABLIM1/SKAP1/RBL2/MGAT4A/SATB1/RPL17/TMEM204/ARHGAP15/CD96/ITGA6/PSIP1/RPS13/MAML2/CLEC2D/PDE3B/RASGRP1/RORA/EIF3E/THEMIS/GCC2/BCL2/FOXP1/NUCB2/SESN3/SLC38A1/NSA2,Genes up-regulated in peripheral blood mononuclear cell Ad5 nAb titers >= 200Ad5 nAb titers <= 200 in adults (20-50) (Ad5 nAb titers > 200) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Impaired down-regulation. Genes with MRKAd5/HIV-induced expression responses significantly impacted by Ad5 nAbs (24hrs). Table includes specific cell types.,C7/VAX
SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,17,0.902928871917008,2.58160875006263,1.26452798775995e-10,7.25729106018751e-10,3.24089552927034e-10,182,tags=88%, list=8%, signal=82%,LDHB/CD3D/LTB/C12orf57/RPS15A/EEF1B2/RPL13/RPS21/RPL9/RPS3A/RPL10A/ZAP70/RPL23A/ARL4C/RPS10,Genes down-regulated in peripheral blood mononuclear cell post-vaccination vs pre-vaccination in adults (18-40) after exposure to YF-Vax or APSV Wetvax (identical responses) , time point anyD. Comment: Significantly Modulated Genes Common to Vaccinia and Yellow Fever Vaccination,C7/VAX
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,46,-0.799172224136065,-2.33342364304871,2.74717802026023e-10,1.51094791114313e-09,6.74745478660407e-10,314,tags=72%, list=14%, signal=63%,CTSD/THEMIS2/ANXA1/FKBP1A/CTSB/TGFBI/CD63/TIMP2/VIM/ASAH1/GLIPR1/PLBD1/RHOC/CD36/LRP1/FCGRT/IGSF6/RNF130/LGALS3/TSPO/S100A10/FGL2/GRN/IFI30/S100A4/MNDA/S100A6/AIF1/CTSS/FTL/FCN1/LYZ/CST3,Genes down-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in infants (10w) after exposure to BCG (Danish strain BCG Statens Serum Institut, Denmark) , time point 10W. Comment: PBMCs drawn at 10 weeks following immunization at birth,C7/VAX
FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,83,-0.700096404211215,-2.25908818106005,3.66531485492512e-10,1.93528624340046e-09,8.64242660529712e-10,410,tags=54%, list=18%, signal=46%,MX1/ETV6/IFI16/TPP1/ANAPC11/UQCRQ/SERPINB6/ATP5MF/NOTCH2/ARF5/ZNF106/MT2A/IRF7/CUX1/TNFSF10/UNC93B1/PIK3AP1/NBPF14/CTSB/OAS1/ODF3B/NAGK/CD63/LILRB1/CLEC7A/TNFSF13B/LRP1/CARD16/CAPG/APLP2/ANXA5/ZEB2/TNFAIP2/TKT/CD14/CYBB/TYMP/S100A4/VCAN/IFITM3/HLA-DQA1/AIF1/PSAP/FCER1G/FCN1,Genes down-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D,C7/VAX
HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,68,-0.728134480772395,-2.28872481822216,9.06786523046051e-10,4.60368542469534e-09,2.0558722789708e-09,362,tags=56%, list=16%, signal=48%,RAB5C/RNPEP/SDCBP/BACH1/SCPEP1/ATP6V1F/MOB1A/REL/IER2/CIITA/GRINA/RNASEK/CDA/SNX2/OGFRL1/CXXC5/ZNF385A/C19orf38/AOAH/ALDH2/VIM/CEBPB/ASAH1/PLBD1/ATP6V0C/LTA4H/HLA-DMB/ATP6V0B/NCF1/SYK/RNF130/PLEK/HLA-DMA/CEBPD/SPI1/TYROBP/HLA-DRA/LYZ,Genes negatively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors (50-74) after exposure to Fluarix , time point 0D,C7/VAX
HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,128,-0.628640906254846,-2.12460769930034,1.23977960541567e-09,6.06114473758773e-09,2.70673130227203e-09,250,tags=50%, list=11%, signal=47%,ARRB2/SKAP2/EIF4EBP1/PPT1/EVI2B/CALM2/RNASE6/FKBP1A/C1orf162/CDA/VSIR/VAMP8/TGFBI/PRAM1/CRTAP/LAT2/SLC11A1/JAML/ALDH2/CLEC7A/TIMP2/PECAM1/GLIPR1/PLBD1/LRRC25/ALOX5/LTA4H/AP2S1/HLA-DMB/CD36/TBXAS1/LY86/LRP1/FPR1/BLVRB/MPEG1/AHNAK/SYK/FCGRT/APLP2/AP1S2/ITGB2/NRGN/RNF130/FOS/SH3BGRL3/CPVL/HLA-DMA/LGALS3/TSPO/CSTA/CD14/MS4A6A/CYBB/COTL1/S100A12/S100A4/VCAN/LST1/AIF1/FCN1/S100A9/LYZ/S100A8,Genes down-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y,C7/VAX
HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,21,-0.896920973240212,-2.26296518848293,1.56572709010477e-09,7.38128485335106e-09,3.2962675581153e-09,214,tags=95%, list=9%, signal=87%,FGD2/GCA/ZNF385A/C19orf38/JAML/TIMP2/IFNGR2/HLA-DMB/LY86/CTSH/ANXA5/IGSF6/TNFAIP2/GRN/IFI30/HLA-DQB1/HLA-DPA1/HLA-DRB1/HLA-DRA/CST3,Genes down-regulated in natural killer cell 28d vs 0d in adults (18-49) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 28D , administered i.m.,C7/VAX
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,37,0.742620502524028,2.48503171697387,5.03021431110895e-09,2.28961478988407e-08,1.02247550425445e-08,243,tags=81%, list=11%, signal=74%,IL7R/CD3E/LEF1/CD3D/IL32/ETS1/GIMAP7/CD3G/LCK/TRAT1/CD27/CD6/MAL/ITK/CD2/ITM2A/CD28/LAT/ZAP70/TRAC/CD96/SIRPG/PRKCH/BCL11B/CD247/RASGRP1/RORA/SIT1/GATA3/TRBC1,Genes down-regulated in peripheral blood mononuclear cell 1d postboost vs 0d pre-imm in children (14-27m) (MF59-adjuvanted) after exposure to Fluad , time point 1D. Comment: (B) Genes in BTM M7.0; (D) Genes in BTM M53,C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,82,-0.673072439857032,-2.17506167287611,1.43920964344393e-08,6.3325224311533e-08,2.82792070290737e-08,530,tags=66%, list=23%, signal=53%,IFI6/OGFR/TRIM38/SP110/STAT2/MYDGF/VAMP5/DRAP1/DYNLT1/MX1/NRROS/IFI16/PARP14/RHBDF2/LY6E/LAP3/CAP1/PLAC8/HSH2D/MYD88/MT2A/IRF7/TNFSF10/UNC93B1/PIK3AP1/ADA2/PSME2/BST2/OAS1/ABI3/RNH1/LGALS9/NAGK/SCIMP/LMO2/PRAM1/LILRB1/MARCKS/TNFSF13B/CD36/CX3CR1/MS4A7/NPC2/CD68/CYBB/TYMP/GRN/IFI30/SAT1/IFITM3/FCER1G/FCN1/CD74/CST3,Genes up-regulated in peripheral blood mononuclear cell 7d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 7D,C7/VAX
NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,182,-0.557914293569957,-1.93991914019966,5.09613309908789e-08,2.16996635186968e-07,9.69043984885982e-08,681,tags=57%, list=30%, signal=43%,AP2A1/SNX5/TRAPPC1/ARF3/RAB7A/SFT2D1/RPS6KA1/BANF1/NEDD8/IL17RA/FIBP/PTPRJ/RABGAP1L/TIMM8B/RAB8A/VDAC1/WASHC4/MIEN1/PRDX1/PPP3CA/ATP6V0E1/MAPK1/CD53/CTSA/UQCR10/NAAA/CLTC/APOBEC3G/OSTF1/TMEM167A/ILK/TMBIM4/RAB10/NAA38/LSM10/TXNDC17/SUPT4H1/NDUFB7/DBNL/TPST2/IFI16/CAT/PPP1CA/LAMTOR2/CKLF/DOK2/CLTA/DBI/CAP1/SERPINB6/PLAC8/ARF5/CSTB/CUX1/REEP5/QKI/BID/PIK3AP1/CD300A/HSBP1/GLRX/RNASE6/CTSC/FKBP1A/DYNLL1/C1orf162/ATP6V1B2/STX7/ABI3/MTSS1/CLEC12A/VAMP8/IQGAP1/PAK1/PRAM1/LYST/CASP1/PGLS/TPI1/SLC7A7/HVCN1/PECAM1/GLIPR1/RHOC/LTA4H/AP2S1/CD36/TBXAS1/LY86/SERF2/CALHM6/TIMP1/POU2F2/CX3CR1/SYK/AP1S2/LILRB2/MS4A7/ZEB2/MS4A6A/LST1/AIF1/FCER1G,Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to Fluarix/Fluvirin , time point 3D. Comment: Supplementary Table 1a: All the differentially expressed genes identified in PBMCs of TIV vaccinees.,C7/VAX
ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,213,0.408270774992141,1.82304769402546,1.76224329062472e-07,7.26925357382696e-07,3.24623764062448e-07,502,tags=34%, list=22%, signal=29%,IL7R/LDHB/LEF1/CD3D/CAMK4/TRAT1/AQP3/LEPROTL1/EEF1B2/NPM1/ITK/RPL34/IL6ST/TMEM123/CD28/RPL24/MGAT4A/RPL17/HINT1/TOMM7/ADD3/PSIP1/BCL11B/RPS7/CLEC2D/FYN/RASGRP1/RPL36A/RORA/EIF3E/THEMIS/ATM/TNFAIP8/RPL26/KIF2A/SNRPD2/NUCB2/GIMAP2/CLDND1/EIF4A2/DOCK10/SLC38A1/NSA2/TMEM106B/URI1/CMPK1/ASF1A/PRKACB/CD69/CCNG1/RPL35/MDFIC/GIMAP6/MRFAP1L1/ARHGEF3/UQCRB/TMEM243/HSPD1/ZRANB2/SRP9/PPA1/STT3B/RBMX/GLS/N4BP2L2/CRBN/G3BP1/SNHG5/ERAP2/CHD2/PNISR/BUB3,Genes up-regulated in blood vaccinated vs control in adults (23-48) after exposure to Live attenuated vaccine TC-83 , time point 14D,C7/VAX
SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,103,-0.619209874675011,-2.03849334658214,2.40793421144881e-07,9.63173684579522e-07,4.30125409381605e-07,551,tags=53%, list=24%, signal=42%,XAF1/ATP6V0E1/PSMA4/GNAS/CD53/PRR13/IFI6/SP110/EIF4A1/NFKBIA/DRAP1/PTP4A2/DYNLT1/MX1/ETV6/FERMT3/CIAO2A/PSMB9/LY6E/LAP3/TUBA1A/SEC61B/PLAC8/HSH2D/NOTCH2/MT2A/COX5A/TNFSF10/ATG3/HSBP1/PSME2/GLRX/OAS1/LMO2/JUNB/IFITM2/CEBPB/MARCKS/PECAM1/TNFSF13B/MPEG1/CX3CR1/LILRB2/MS4A7/ANXA2/PLEK/TNFAIP2/FGR/S100A11/IFI30/SAT1/IFITM3/SERPINA1/TYROBP/CD74,Genes up-regulated in peripheral blood mononuclear cell (4 to 7)d vs 0d in adults (18-40) after exposure to YF-Vax , time point 4 to 7D,C7/VAX
KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,100,-0.625291634438394,-2.04865934286849,2.70834817784431e-07,1.05147635139838e-06,4.69558817211397e-07,497,tags=48%, list=22%, signal=39%,PGAM1/OS9/PSMB8/RTN3/SPG21/RNF213/ILK/PKM/LAPTM5/LMO4/PPP1CA/WASF2/TUBA1A/NCF4/REL/QKI/COMT/PRKCB/BTK/BST2/LILRB3/CPPED1/GNB2/CAST/CAPNS1/PRAM1/ATP6V0D1/CD63/ALDH2/SLC7A7/CNPY3/LRRC25/ALDOA/GNAI2/ATP6V0B/LSP1/SYK/CAPG/APLP2/CFP/GAPDH/RNF130/CPVL/TNFAIP2/CD14/GRN/FTH1/SERPINA1,Genes down-regulated in blood cohort 1 (re-vaccinated in 6-9 months) vs cohort 2 (re-vaccinated in 12-13 months) in adults (65+) after exposure to 2012-2013 seasonal trivalent inactivated influenza vaccine (TIV) , time point N/A. Comment: Cohort 1 (re-vaccinated in 6-9 months) vs Cohort 2 (re-vaccinated in 12-13 months),C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,66,-0.672203354549946,-2.1093158094404,4.94007781326766e-07,1.8631150610038e-06,8.32013105392448e-07,378,tags=67%, list=16%, signal=57%,IFI6/OGFR/TRIM38/SP110/STAT2/DRAP1/MX1/NRROS/IFI16/PARP14/RHBDF2/LY6E/LAP3/PLAC8/MYD88/MT2A/IRF7/TNFSF10/ADA2/PSME2/BST2/OAS1/ABI3/RNH1/LGALS9/NAGK/SCIMP/LMO2/PRAM1/CASP1/LILRB1/TNFSF13B/CX3CR1/MS4A7/NPC2/CD68/CYBB/TYMP/GRN/IFI30/IFITM3/FCER1G/FCN1/CST3,Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 3D,C7/VAX
FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,116,0.474178829474156,1.98456141855193,6.45141355898645e-07,2.3655183049617e-06,1.05637181082819e-06,464,tags=48%, list=20%, signal=41%,IL7R/TCF7/LDHB/LEF1/SARAF/PRKCQ-AS1/CD27/RPS4X/EEF1G/ABLIM1/ITM2A/TAGAP/THEM4/HSPA8/RPL22/S1PR1/ADD3/ITGA6/PSIP1/EIF4B/GPR183/CLEC2D/FCMR/RASGRP1/FAM102A/RORA/TNFRSF25/IKZF1/LINC01550/MBNL1/ATM/BCL2/EIF2S3/MLLT3/FOXP1/FAM107B/FOXO1/STK17A/TTC39C/CDC42SE2/DOCK10/SLC38A1/HIVEP2/SHISAL2A/PRKACB/CCNG1/MDFIC/SKP1/EIF3L/ARHGEF3/EML4/SPTBN1/HSPD1/OGT/RBMX/ID3,Genes up-regulated in blood responders vs poor responders in adults (25-83) (responders) after exposure to Twinrix , time point 0D,C7/VAX
LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,12,-0.913351028085555,-2.02209616241198,1.25577382131721e-06,4.48005795713168e-06,2.00066384050537e-06,68,tags=58%, list=3%, signal=57%,HLA-DMA/HLA-DQB1/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA/CD74,Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) after exposure to Menomune A/C/Y/W-135 , time point 3D,C7/VAX
SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,15,0.835340224768177,2.30676000479121,1.48173290184355e-06,5.01509597547047e-06,2.23959628888634e-06,202,tags=67%, list=9%, signal=61%,CD3E/CD3D/CD3G/LCK/LAT/ZAP70/PLCG1/CD247/FYN/RASGRP1,Genes up-regulated in T cell 1d vs 0d in adults (18-64) after exposure to Pandemrix (A/California/7/09 (H1N1)) , time point 1D. Comment: - roughly 60/40 female:male ratio, over 70% were Causasian,C7/VAX
SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,15,0.835340224768177,2.30676000479121,1.48173290184355e-06,5.01509597547047e-06,2.23959628888634e-06,202,tags=67%, list=9%, signal=61%,CD3E/CD3D/CD3G/LCK/LAT/ZAP70/PLCG1/CD247/FYN/RASGRP1,Genes down-regulated in T cell 7d vs 1d in adults (18-64) after exposure to Pandemrix (A/California/7/09 (H1N1)) , time point 7D. Comment: - roughly 60/40 female:male ratio, over 70% were Causasian,C7/VAX
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,12,-0.90794907540663,-2.01013661187151,2.08260842678288e-06,6.87260780838349e-06,3.06910715525897e-06,139,tags=75%, list=6%, signal=71%,HLA-DMB/TNFSF13B/TBXAS1/HLA-DQB1/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA/CD74,Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) (anti-DT antibody-correlation profile) after exposure to Menactra , time point 3D,C7/VAX
NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,105,-0.589259511450852,-1.94714410807032,2.9270625716536e-06,9.4237136453238e-06,4.20835697079851e-06,395,tags=32%, list=17%, signal=28%,YWHAH/PPP1CA/PTPN12/CLTA/IFNGR1/COX5B/SKAP2/QKI/LYL1/CD300A/BST2/SWAP70/TGFBI/CAPNS1/ATP6V0D1/CLEC7A/SERPINB1/PECAM1/ALOX5/TIMP1/AHNAK/NCF2/SRGN/LGALS3/LYN/FGR/IFI30/MNDA/CEBPD/LGALS1/HLA-DRB5/HLA-DRB1/LYZ/S100A8,Genes down-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D,C7/VAX
HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,121,0.442588304497518,1.87129221222418,5.55181867245321e-06,1.74485729705672e-05,7.79202620695187e-06,407,tags=30%, list=18%, signal=26%,CD3D/IL32/PCED1B-AS1/IFITM1/RPS27A/RPL32/RPS6/RPL14/LIME1/RPS29/PBXIP1/RPS23/RPL37/RPL39/PRMT2/HINT1/EEF1D/RPL23A/SOD1/RPS7/CLEC2D/NAP1L4/SNRPN/RPS19/RPL13A/OPTN/TTC39C/ATP6V0E2/SIGIRR/GLG1/THOC3/DGKZ/HMOX2/IL2RG/PPP2R5C/SKP1,Genes positively correlated with memory B cell response at 28d in peripheral blood mononuclear cell in seniors(50-74) after exposure to Fluarix , time point 0D,C7/VAX
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,13,-0.889896455251053,-2.01429596084536,1.09055060880714e-05,3.34773675261728e-05,1.49500205858507e-05,136,tags=62%, list=6%, signal=58%,TNFSF13B/TBXAS1/HLA-DMA/HLA-DQA1/HLA-DPB1/HLA-DPA1/HLA-DRB1/HLA-DRA,Genes positively correlated with antibody response in peripheral blood mononuclear cell in adults (18-45) (anti-polysaccharide antibody-correlation profile) after exposure to Menactra , time point 3D,C7/VAX
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,39,-0.710377974087484,-2.02974415655108,1.13706599110354e-05,3.41119797331062e-05,1.52334199765068e-05,387,tags=59%, list=17%, signal=50%,CDC42EP3/RNASET2/RNPEP/IRF1/ZYX/C1orf162/VSIR/RHOG/LGALS9/CRTAP/ALDH2/CNPY3/TNFRSF1B/ALOX5/ALDOA/MPEG1/AP1S2/ANXA5/ITGB2/TSPO/FGR/GRN/PSAP,Genes down-regulated in peripheral blood mononuclear cell 2d vs 0d in seniors (70+) (nonresponder) after exposure to Inactivated influenza vaccine , time point 2D,C7/VAX
NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,160,0.392191552827642,1.71578771055219,2.55297657575474e-05,7.48873128888058e-05,3.34425001736294e-05,511,tags=28%, list=22%, signal=23%,CAMK4/SPOCK2/RPS27/RGCC/LEPROTL1/NDFIP1/PBXIP1/ITM2A/CD28/RHOH/S1PR1/CYLD/PSIP1/ARL4C/PRKCH/RORA/GATA3/SPTAN1/DNAJB1/PHF1/FOXP1/DDX24/CLDND1/TNIK/FOXO1/STK17A/SFXN1/PIK3R1/CNST/EPC1/RASA2/CCDC66/GPRIN3/CD69/PPP2R5C/PDCD4/SERINC1/EML4/STT3B/SORL1/MTERF4/CHD2/PNISR/RBM38/WIPF1,Genes down-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Supplementary Table 1b: All the differentially expressed genes identified in PBMCs of TIV vaccinees.,C7/VAX
MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,22,-0.794986993968641,-2.02994972105753,3.45228420988826e-05,9.90655468924457e-05,4.42397976553186e-05,291,tags=68%, list=13%, signal=60%,TNFSF10/BID/BST2/LGALS9/CASP1/IFITM2/CARD16/PILRA/CD68/PYCARD/CFD/TYMP/IFITM3/S100A9/S100A8,Genes up-regulated in peripheral blood mononuclear cell 2d vs 0d in adult (18-55) after exposure to Modified Vaccinia Ankara (MVA) virus vaccine vector , time point 2D,C7/VAX
FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,15,-0.84207036890874,-1.96228403327532,4.2749032921903e-05,0.000120061113738111,5.36158083678962e-05,139,tags=47%, list=6%, signal=44%,HLA-DMB/CD68/HLA-DMA/HLA-DQB1/FCER1G/HLA-DRB1/CD74,Genes up-regulated in peripheral blood mononuclear cell 48h vs 0h in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 48H,C7/VAX
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,127,-0.536810220755764,-1.81412362756091,5.52134722845639e-05,0.000151837048782551,6.78060185950784e-05,290,tags=34%, list=13%, signal=31%,ACAP2/RNASET2/PSMB10/ARPC5/CAP1/NCOA4/PPT1/PLCG2/LCP1/CD300A/HERPUD1/GDI2/RAB11FIP1/PRKCB/CALM2/PRKCD/ATP6V1B2/TAGLN2/VSIR/RAB24/RHOG/LMO2/CAPNS1/NCF1C/YBX3/ALDH2/TNFRSF1B/MARCKS/ALOX5/GNAI2/TALDO1/ITGB2/RNF130/FOS/CPVL/CD14/FGR/CYBB/GRN/CYBA/SERPINA1/PSAP/HLA-DRA,Genes positively correlated with contraction of VZV specific T cells (peak to 28d) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D,C7/VAX
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,28,0.656884637611777,2.09445534426787,6.32623908912424e-05,0.000170421134645796,7.61051318992389e-05,363,tags=43%, list=16%, signal=37%,LDHB/NOSIP/C12orf57/LEPROTL1/RPL14/TC2N/OCIAD2/THEMIS/FKBP5/FAM107B/CDC42SE2/ASF1A,Genes up-regulated in peripheral blood mononuclear cell 2d vs 0d in seniors (70+) (nonresponder) after exposure to Inactivated influenza vaccine , time point 2D,C7/VAX
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,106,-0.54375107679484,-1.79491201956991,6.80486482662566e-05,0.000179648431422917,8.02257747981131e-05,413,tags=39%, list=18%, signal=33%,RASSF2/MFSD1/YWHAH/ACAP2/RNPEP/ARPC5/TUBA1A/PFN1/MOB1A/ZNF106/PPT1/EVI2B/PLCG2/HERPUD1/RAB11FIP1/CALM2/TAGLN2/VSIR/RHOG/LILRB3/CAST/SLC11A1/ALDH2/TNFRSF1B/PECAM1/LRRC25/ALOX5/PGD/FPR1/LSP1/TALDO1/LILRB2/ITGB2/RNF130/CD14/GABARAP/EFHD2/SPI1/SERPINA1/CTSS/PSAP,Genes positively correlated with expansion of VZV specific T cells (0d to peak) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D,C7/VAX
FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,14,-0.854588047972425,-1.94939211896319,0.000113464319551663,0.000293672356486656,0.000131145549946194,139,tags=50%, list=6%, signal=47%,HLA-DMB/CD68/HLA-DMA/HLA-DQB1/FCER1G/HLA-DRB1/CD74,Genes up-regulated in peripheral blood mononuclear cell 18hr vs 0hr in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 18H,C7/VAX
PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,66,-0.599917455446481,-1.88248892923145,0.000117327860911458,0.000297832262313701,0.000133003243138495,165,tags=30%, list=7%, signal=29%,GCA/CLEC7A/SERPINB1/DUSP6/IFNGR2/MARCKS/FPR1/CALHM6/LILRB2/SRGN/PLEK/ZEB2/LYN/FGL2/TNFAIP2/FGR/EFHD2/VCAN/SERPINA1/LYZ,Genes up-regulated in skin of body 6hr vs 0hr in adults (70-93) (VZV challenge) after exposure to Zostavax , time point 6H,C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,12,-0.849363306112562,-1.88043176059455,0.000188216123598757,0.000468764685189356,0.000209336701519968,270,tags=75%, list=12%, signal=67%,ADA2/LGALS9/NAGK/SCIMP/NPC2/CYBB/IFI30/FCN1/CD74,Genes up-regulated in peripheral blood mononuclear cell 60d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 60D,C7/VAX
MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,14,-0.839758569655467,-1.91556474654908,0.000297374908773087,0.000726916443667545,0.000324619783456001,304,tags=86%, list=13%, signal=75%,CUX1/LYL1/TGFBI/CD63/FCGRT/ANXA5/NCF2/PLEK/LYN/CD14/FGR/FTL,Genes up-regulated in peripheral blood mononuclear cell vaccinated vs control in adults (18-55) (treated in vitro with MVA85A) after exposure to Modified Vaccinia Ankara (MVA) virus vaccine vector , time point 6H,C7/VAX
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,33,-0.678515820878512,-1.88314368187668,0.000454269698585818,0.00109024727660596,0.000486872787001068,551,tags=79%, list=24%, signal=61%,XAF1/IFI6/TRIM38/SP110/MX1/IFI16/WSB1/LY6E/LAP3/HSH2D/TNFSF10/OAS1/ABI3/MTSS1/FGD2/LGALS9/CLEC7A/DUSP6/MARCKS/LRRC25/TNFSF13B/CX3CR1/IGSF6/GRN/IFITM3/LST1,Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 3D. Comment: Table includes specific cell types,C7/VAX
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,94,0.410273387465072,1.65708766624208,0.000548556000833468,0.00129302485910746,0.000577427369298388,265,tags=29%, list=12%, signal=26%,C12orf57/RPS27/RPS27A/EEF1B2/RPL14/TPT1/RPS5/RPS29/RPL36/RPS3A/RPL11/ITM2A/RPL4/PRMT2/RPL17/TOMM7/RPL18A/OCIAD2/EEF1D/FAM102A/PTPRCAP/ARHGEF1/STMN3/RPL26/SF1/PTPRC/SNRPD2,Genes negatively correlated with contraction of VZV specific T cells (peak to 28d) in peripheral blood mononuclear cell in seniors (50-75) after exposure to Zostavax , time point 1D,C7/VAX
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,125,0.370646291219021,1.57403554111529,0.0006699312573934,0.00155141975396366,0.000692819028883295,402,tags=27%, list=18%, signal=24%,NOSIP/CD3G/INPP4B/LEPROTL1/EEF1B2/TC2N/RPL34/RPS3A/TMEM123/GYPC/PPP1R2/TOMM7/ADD3/NCK2/GPR183/PIM1/SOD1/CLEC2D/BCL2/KIF2A/RETREG1/OPTN/BEX3/NUCB2/GIMAP2/PIK3R1/TSTD1/UBQLN2/ANKRD12/NSA2/EPC1/RGS10/CCNG1/MAT2B,Genes up-regulated in peripheral blood mononuclear cell 28d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 28D,C7/VAX
SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,29,-0.690982233492494,-1.86580888509307,0.000927033264001119,0.00207404052284996,0.000926206294095676,614,tags=90%, list=27%, signal=66%,PSMA6/ISG15/PSME1/XAF1/PSMA4/IFI6/SP110/EIF4A1/MX1/PSMB9/LY6E/LAP3/TNFSF10/HSBP1/PSME2/GLRX/OAS1/LMO2/IFITM2/CEBPB/MARCKS/ANXA2/IFI30/IFITM3/SERPINA1/CD74,Genes up-regulated in peripheral blood mononuclear cell post-vaccination vs pre-vaccination in adults (18-40) after exposure to APSV Wetvax , time point anyD. Comment: Significantly Modulated Genes Common to Vaccinia and Yellow Fever Vaccination,C7/VAX
SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,29,-0.690982233492494,-1.86580888509307,0.000927033264001119,0.00207404052284996,0.000926206294095676,614,tags=90%, list=27%, signal=66%,PSMA6/ISG15/PSME1/XAF1/PSMA4/IFI6/SP110/EIF4A1/MX1/PSMB9/LY6E/LAP3/TNFSF10/HSBP1/PSME2/GLRX/OAS1/LMO2/IFITM2/CEBPB/MARCKS/ANXA2/IFI30/IFITM3/SERPINA1/CD74,Genes up-regulated in peripheral blood mononuclear cell post-vaccination vs pre-vaccination in adults (18-40) after exposure to YF-Vax , time point anyD. Comment: Significantly Modulated Genes Common to Vaccinia and Yellow Fever Vaccination,C7/VAX
FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,25,0.617024691175602,1.91389310040813,0.00121094845228718,0.00266408659503179,0.00118970374259793,230,tags=56%, list=10%, signal=51%,CD3E/NOSIP/CD3D/CD3G/KLF2/CD28/RHOH/ZAP70/CD96/PRKCH/RORA/TNFRSF25/PTPRCAP/STMN3,Genes down-regulated in peripheral blood mononuclear cell (18 to 48)h vs 0h in adults (22-54) after exposure to F. tularensis vaccine LVS , time point 18 to 48H. Comment: Pattern 4, down early. These 21 of 56 genes in pattern linked to immune-related functions.,C7/VAX
HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,89,-0.520939204425248,-1.6989310224123,0.00145415190013748,0.00314668935767455,0.00140522012782914,410,tags=49%, list=18%, signal=42%,IFI6/TRIM38/CTSA/STAT2/APOBEC3G/PSMB8/VAMP5/RNF213/MX1/IFI16/TMSB10/PSMB10/PARP14/RHBDF2/PSMB9/LY6E/LAP3/SERPINB6/IRF1/MT2A/IRF7/GSTO1/PIK3AP1/CIITA/PSME2/GRINA/BST2/OAS1/ODF3B/RHOC/HLA-DMB/TNFSF13B/CALHM6/CARD16/NPC2/HLA-DMA/TYMP/IFI30/HLA-DQB1/IFITM3/HLA-DRB5/HLA-DRB1/HLA-DRA/CD74,Genes up-regulated in neutrophil 1d vs 0d in adults (18-49) after exposure to inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine , time point 1D , administered i.m.,C7/VAX
FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,45,-0.599776309632935,-1.74738060640245,0.00167402245931654,0.00354988175123163,0.00158527414728047,648,tags=73%, list=28%, signal=54%,UBE2L6/IFI35/CASP4/ISG15/PSME1/XAF1/IFI6/SP110/STAT2/DRAP1/LPGAT1/DYNLT1/MX1/IFI16/PARP14/PSMB9/LY6E/LAP3/MT2A/IRF7/UNC93B1/CD300A/OAS1/SCIMP/LMO2/CASP1/TNFSF13B/FGL2/TYMP/IFI30/SAT1/FCER1G/CD74,Genes positively correlated with antibody response in blood in adults (18-40) after exposure to Sanofi Pasteur, SA, Inactivated influenza vaccine , time point 1D,C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,49,-0.595625380653682,-1.76483693539625,0.001694261744906,0.00354988175123163,0.00158527414728047,551,tags=63%, list=24%, signal=49%,XAF1/IFI6/TRIM38/SP110/STAT2/VAMP5/DRAP1/MX1/IFI16/PARP14/LY6E/LAP3/PLAC8/MT2A/IRF7/TNFSF10/PSME2/BST2/OAS1/ABI3/LGALS9/NAGK/LMO2/CASP1/CALHM6/CX3CR1/NPC2/CYBB/IFI30/SAT1/IFITM3,Genes up-regulated in peripheral blood mononuclear cell 10d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 10D,C7/VAX
HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,80,-0.534017003505121,-1.72500531793714,0.00175007598884295,0.00360953172698859,0.00161191209498693,551,tags=55%, list=24%, signal=43%,XAF1/NINJ1/IFI6/TRIM38/SP110/STAT2/APOBEC3G/VAMP5/DRAP1/RNF213/DYNLT1/MX1/MYO1G/PARP14/NADK/RHBDF2/PSMB9/LY6E/LAP3/DAPP1/IRF1/HSH2D/MT2A/IRF7/TNFSF10/BST2/OAS1/FGD2/DUSP1/LGALS9/CASP1/LILRA5/SNX10/IFITM2/DUSP6/RHOC/TNFSF13B/CALHM6/PILRA/NCF1/LILRB2/LGALS2/LYN/IFITM3,Genes up-regulated in peripheral blood mononuclear cell vaccinated vs unvaccinated in adolescent/young adults (11-22) after exposure to M-M-R II , time point 7Y,C7/VAX
NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,98,0.384574580594357,1.58596994016373,0.00281121011661687,0.00570891900605271,0.00254943751466469,745,tags=50%, list=32%, signal=35%,CCR7/ETS1/PIK3IP1/ITK/SKAP1/RBL2/RPL28/BIN1/IL16/ATM/DNAJB1/ST13/FKBP5/RIPOR2/STK17A/SH3YL1/CRLF3/ANKRD12/RPL37A/ZBTB25/SIGIRR/ASF1A/SKP1/UXS1/MFNG/IL27RA/RRP1B/FAM117A/RUNX1/GRK6/CCDC88C/CCT4/DBP/CPSF6/INPP4A/CCND3/CREBZF/CDC42SE1/HAX1/APEX1/UBE2B/SMCHD1/RSRP1/RBBP6/PNN/TAZ/CACYBP/ST6GAL1/SF3A3,Genes up-regulated in B cell 7d vs 0d in young adults (18-50) after exposure to FluMist , time point 7D,C7/VAX
GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,12,0.734962396255878,1.89679217810728,0.00302274856573484,0.00604549713146968,0.00269974353558455,422,tags=75%, list=18%, signal=62%,IL7R/ITM2A/RPL22/RPLP0/SNRPN/STMN3/ATM/CMPK1/EIF3F,Genes down-regulated in peripheral blood mononuclear cell 28d vs 0d in unknown after exposure to YF-Vax/Stamaril , time point 28D,C7/VAX
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,16,0.664220462207602,1.86586007165248,0.00315665995696546,0.00621909125849912,0.00277726563377951,356,tags=44%, list=16%, signal=37%,MGAT4A/CLEC2D/GCC2/KIF2A/PIK3R1/ANKRD12/RASA2,Genes positively correlated with CD8+ T-cell response in peripheral blood mononuclear cell in adults (20-50) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 3D,C7/VAX
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,171,-0.443051353367789,-1.53298433366563,0.00328238276753048,0.00637168419579446,0.00284540921024314,347,tags=23%, list=15%, signal=21%,DAPP1/SULT1A1/MBD2/ZYX/ARRB2/CUX1/NBPF14/HERPUD1/GRB2/ADA2/TCIRG1/PRKCD/C1orf162/RHOG/LILRB3/DUSP1/CRTAP/SLC11A1/CLEC7A/CNPY3/PTPRE/CEBPB/ALOX5/ALDOA/CD302/PILRA/MPEG1/NCF1/CSF3R/ITGB2/HLA-DMA/S100A10/LYN/EFHD2/GRN/S100A4/MNDA/CEBPD/SERPINA1/PSAP,Genes down-regulated in peripheral blood mononuclear cell 7d vs 0d in young adults (21-30) (responders) after exposure to Inactivated influenza vaccine , time point 7D. Comment: most (70-80%) of cohort were white,C7/VAX
GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,32,-0.628351331975857,-1.73438332794948,0.00471965753147593,0.00902891006021481,0.00403204914969721,551,tags=75%, list=24%, signal=58%,XAF1/IFI6/SP110/VAMP5/DYNLT1/MX1/ADGRE5/PSMB9/LY6E/LAP3/IRF1/MT2A/IRF7/TNFSF10/PSME2/BST2/OAS1/LMO2/IFITM2/DUSP6/FGL2/TYMP/MNDA/IFITM3,Genes up-regulated in peripheral blood mononuclear cell stimulated vs unstimulated in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 0D. Comment: List of Genes induced by VLP directly, independently of vaccination (p<0.05 and FC>1.30),C7/VAX
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,11,-0.78681167716221,-1.70891895666131,0.00495202830524982,0.0093381105184711,0.00417012909915775,291,tags=91%, list=13%, signal=80%,NFKBIA/AKR1A1/TNFSF10/ABI3/CLEC12A/SLC11A1/LILRB1/PILRA/CFD/LGALS1,Genes down-regulated in peripheral blood mononuclear cell Ad5 nAb titers > 200 vs Ad5 nAb titers <= 200 in adults (20-50) (Ad5 nAb titers > 200) after exposure to MRKAd5 HIV-1 gag/pol/nef , time point 1D. Comment: Impaired up-regulation. Genes with MRKAd5/HIV-induced expression responses significantly impacted by Ad5 nAbs (24hrs). Table includes specific cell types.,C7/VAX
NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,18,-0.715119909556163,-1.77665217284226,0.00559703320351535,0.0104057518713243,0.00464690673679555,551,tags=89%, list=24%, signal=68%,XAF1/STAT2/MX1/PSMB10/PSMB9/MYD88/IRF7/TNFSF10/UNC93B1/CIITA/CTSB/OAS1/CASP1/PECAM1/TNFSF13B/CD14,Genes up-regulated in peripheral blood mononuclear cell 3d vs 0d in adults (18-50) after exposure to FluMist , time point 3D. Comment: Molecular signature induced by LAIV vaccination. (a) Interferon (IFN)-related genes differentially expressed after LAIV vaccination,C7/VAX
GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,72,-0.486884198306468,-1.54938326371333,0.0150167043554879,0.0275306246517277,0.0122943778349023,181,tags=26%, list=8%, signal=25%,SLC11A1/TIMP2/ASAH1/PECAM1/ALOX5/TBXAS1/LY86/LRP1/BLVRB/FCGRT/CSF3R/RNF130/PYCARD/CD14/CFD/GRN/CYBA/CEBPD/S100A8,Genes down-regulated in peripheral blood mononuclear cell 2m vs 0m in young adults (18-25) after exposure to HPV-16 L1 VLP , time point 2M. Comment: Gene Expression with Neutralizing Antibody Levels,C7/VAX
SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,45,-0.528493793235026,-1.53970703755893,0.016611854538096,0.0300378739592969,0.0134140425974532,291,tags=36%, list=13%, signal=32%,VCL/DOK2/TNFSF10/COMT/DYNLL1/ATP6V1B2/OAS1/VAMP8/RAB32/CD79B/TLN1/PTPN6/CX3CR1/FGL2/FGR/CTSZ,Genes down-regulated in peripheral blood mononuclear cell (50 to 60)d vs 0d in adults (18-32) after exposure to APSV Wetvax , time point 50 to 60D,C7/VAX
